期刊文献+

那格列奈的合成 被引量:5

Synthesis of nateglinide
下载PDF
导出
摘要 目的:合成抗2型糖尿病药物那格列奈。方法:以对异丙基苯甲醛为原料,经氧化、催化氢化、在高温高压碱性条件下,将顺式-对异丙基环已甲酸异构化为反武.异构体,然后与D-苯丙氨酸甲酯盐酸盐缩合、水解,合成那格列奈。结果:反应中间体以及目标产物的化学结构均经过了光谱分析确证,反应总收率为28.7%。结论:本方法步骤简单,易于工业化生产。 Objective:To synthesize nateglinide, an anti-type 2 diabetic agent. Methods: Starting from 4-isopropylbenzaldehyde, trans-4-isopropylcyclohexanecarboxylic acid was isomerized to cis-isomer via oxidation, catalytic hydrogenation and then high temperature and high pressure in alkali aqueous. Nateglinide was synthesized after the cis-isomer was reacted with D-phenylalanine and hydrolysis. Results: The structures of intermediates and the target product were verified by spectroscopic analysis. The overall yield was 28.7%. Conclusion: The simplified method to synthesize nateglinide was warranted to have further pilot manufacture.
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第18期1564-1566,共3页 Chinese Journal of New Drugs
基金 广东省自然科学基金(4300235)
关键词 那格列奈 2型糖尿病 药物合成 nateglinide type 2 diabetes synthesis
  • 相关文献

参考文献10

二级参考文献55

  • 1Takesada H, Matsuda K, Ohtake R, et al. Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine-derivative hypoglycemic agent [J]. Bioorg Med Chem, 1996,4(10) :1771 - 1781.
  • 2Hollander P,Schwarz S,Gatlin M,et al. Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes[J]. Diabetes Care,2001,24(6) :983 - 988.
  • 3Horton ES, Clinkingbeard C, Gat[in M, et al. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes [J]. Diabtes Care, 2000,23 (11): 1660 - 1665.
  • 4Kikuchi M.Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycemic agents,NN-623 and A-4166[J].Diabet Med,1996,13∶131-135.
  • 5Choudhury S,Hirschberg Y,Filkipek R,et al.Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis[J].J Clin Pharmacol,2000,40(6)∶634-640.
  • 6Takesada H, Matsuda K,Ohtake R,et al.Structure determination of metabolites isolated from urine and bile after administration of AY4166,a novel D-phenylalanine-derivative hypoglycemic agent[J].Bioorg Med Chem,1996,4∶1771-1781.
  • 7Hirschberg Y,Karara AH,Pietri AO,et al.Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin[J].Diabetes Care,2000,23(3)∶349-353.
  • 8Rosenstock J,Gatlin M,Mallows S,et al.Nateglinide improves glycemic control alone and in combination with troglitazone in patients with type 2 diabetes[J].Diabetes,2000,49(Suppl 1)∶S123.
  • 9Yoshiko S,Mariko F,Katsuaki D,et al.Studies on anti-diabetic activity of amino acid derivates (I)[J].Jpn J Pharmacol,1982,32(Suppl)∶S269.
  • 10Hisashi S,Koji T,Izumi K,et al.N-acylphenylalanines and related compounds:a new class of oral hypoglycemic agents[J].J Med Chem,1988,31∶2092-2097.

共引文献88

同被引文献48

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部